A New Way of Cardiac Denervation to Reduce the Incidence of AF After CABG.
Assessing a New Way of Cardiac Denervation to Reduce the Incidence of Atrial Fibrillation After Coronary Artery Bypass Grafting.
1 other identifier
interventional
430
1 country
1
Brief Summary
This is a prospective, random controlled trial(RCT) study. 430 patients undergoing coronary artery bypass grafting were enrolled. Our new way of cardiac denervation, defined as excision of Marshall ligament and Waterstone fat pad, was performed in 215 patients, and the other 215 patients were used as control subjects. All the patients need to equip with electronic monitor to record heart rhythms within 6 days after CABG. The investigators will compare the incidence of postoperative atrial fibrillation between two groups, and follow up 30 days after discharged.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2021
CompletedFirst Posted
Study publicly available on registry
August 18, 2021
CompletedStudy Start
First participant enrolled
August 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2024
CompletedMay 13, 2024
May 1, 2024
1.3 years
June 29, 2021
May 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of POAF during hospital.
Incidence of postoperative atrial fibrillation after surgery during hospital.
6 days after surgery.
Secondary Outcomes (8)
Incidence of massive haemorrhage needing blood transfusion caused by cardiac denervation.
Postoperative hospitalization, an average of 8 days.
Incidence of transferring to on-pump CABG caused by cardiac denervation.
Intraoperatively.
Incidence of re-operation aiming to stop bleeding caused by cardiac denervation.
Postoperative hospitalization, an average of 8 days.
Incidence of pericarial effusion within 30 days after discharged.
within 30 days after discharged.
Incidence of arrhythmia exclude of AF within 30 days after discharged.
within 30 days after discharged.
- +3 more secondary outcomes
Study Arms (2)
cardiac denervation group
EXPERIMENTALIn this group, patients undergoing CABG will receive the procedure of our new way of cardiac denervation, excision of Marshall ligament and Waterstone fat pad.
controlled group
NO INTERVENTIONIn this group ,patients undergoing CABG will not receive the procedure of cardiac denervation.
Interventions
Excision of Marshall ligament and Waterstone fat pad during CABG.
Eligibility Criteria
You may qualify if:
- Patients undergoing simple CABG (on-pump/off-pump) for the first time.
- Patients who signed the informed consent form and willing to undergo cardiac denervation.
You may not qualify if:
- Age \< 18;
- Emergent CABG;
- Cardiac surgery history;
- Receiving other cardiac surgery except of CABG at the same time, such as Morrow、valvular surgery、ventricular aneurysm surgery、congenital heart diseases surgery;
- Requiring mechanical or pharmacological therapy for hemodynamic support before CABG, such as ECMO or IABP;
- History of AF ;
- Taking antiarrhythmic agents except of beta-blockers last 2 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Related Publications (1)
Yang Z, Tiemuerniyazi X, Xu F, Wang Y, Sun Y, Yan P, Tian L, Han C, Zhang Y, Pan S, Hu Z, Li X, Zhao W, Feng W. Partial Cardiac Denervation to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: The pCAD-POAF Randomized Clinical Trial. JAMA Cardiol. 2025 Jan 1;10(1):71-77. doi: 10.1001/jamacardio.2024.4639.
PMID: 39550720DERIVED
Study Officials
- STUDY CHAIR
Wei Feng, MD PhD
Chinese Academy of Medical Sciences, Fuwai Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2021
First Posted
August 18, 2021
Study Start
August 15, 2022
Primary Completion
December 13, 2023
Study Completion
January 30, 2024
Last Updated
May 13, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share